External validation of genetically predicted protein biomarkers for pancreatic cancer risk using aptamer-based plasma levels: A prospective analysis in the Atherosclerosis Risk in Communities Study.

MLA

Liu, Tanxin, et al. “External Validation of Genetically Predicted Protein Biomarkers for Pancreatic Cancer Risk Using Aptamer-Based Plasma Levels: A Prospective Analysis in the Atherosclerosis Risk in Communities Study.” International Journal of Cancer, vol. 153, no. 6, Sept. 2023, pp. 1201–16. EBSCOhost, https://doi.org/10.1002/ijc.34624.

APA

Liu, T., Joshu, C. E., Lu, J., Prizment, A., Chatterjee, N., Coresh, J., Wu, L., & Platz, E. A. (2023). External validation of genetically predicted protein biomarkers for pancreatic cancer risk using aptamer-based plasma levels: A prospective analysis in the Atherosclerosis Risk in Communities Study. International Journal of Cancer, 153(6), 1201–1216. https://doi.org/10.1002/ijc.34624

Chicago

Liu, Tanxin, Corinne E Joshu, Jiayun Lu, Anna Prizment, Nilanjan Chatterjee, Josef Coresh, Lang Wu, and Elizabeth A Platz. 2023. “External Validation of Genetically Predicted Protein Biomarkers for Pancreatic Cancer Risk Using Aptamer-Based Plasma Levels: A Prospective Analysis in the Atherosclerosis Risk in Communities Study.” International Journal of Cancer 153 (6): 1201–16. doi:10.1002/ijc.34624.